相关产品推荐更多 >

P00573 Recombinant Human CTLA-4/CD152/Cytotoxic T-lymphocyte Protein 4 细胞因子/蛋白
¥728
P01303 Recombinant Human F13a/Coagulation Factor XIII A Chain 细胞因子/蛋白
¥1092
P00392 Recombinant Human TRAIL R2/TNFRSF10B/CD262/DR5/KILLER/Fas-like protein 细胞因子/蛋白
¥416
P00356 Recombinant Human B2M/β2-Microglobulin/Beta-2-microglobulin 细胞因子/蛋白
¥312
P01254 Recombinant Human HSPB7/Heat shock protein beta-7 细胞因子/蛋白
¥1092
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
现询
- 供应商:
北京索莱宝科技有限公司
- 规格:
1mg/500ug/50ug/10ug
| 规格: | 1mg | 产品价格: | ¥21120.0 |
|---|---|---|---|
| 规格: | 500ug | 产品价格: | ¥14784.0 |
| 规格: | 50ug | 产品价格: | ¥3276.0 |
| 规格: | 10ug | 产品价格: | ¥1092.0 |
| 基本信息 | |
| 基因名 | |
| 别名 | Peptidyl-prolyl cis-trans isomerase FKBP2(FKBP2 for short);also named 13 kDa FK506-binding protein;FK506-binding protein 2;Immunophilin FKBP13;Rotamase |
| 外观(性状) | Supplied as a 0.2 μm filtered solution of 20mM TrisHCl,150mm NaCl,pH7.5. |
| 纯度 | ≥95% as determined by reducing SDS-PAGE. |
| 储存条件 | Store at ≤-70°C, stable for 6 months after receipt. Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles. |
| 运输条件 | 干冰运输 |
| 背景说明 | Peptidyl-prolyl cis-trans isomerase FKBP2(FKBP2 for short),also named 13 kDa FK506-binding protein,FK506-binding protein 2,Immunophilin FKBP13,Rotamase,is a endoplasmic reticulum peripheral membrane protein.It contains 1 PPIase FKBP-type domain and belongs to the FKBP-type PPIase family,FKBP2 subfamily which takes part in immunoregulation and basic cellular processes involving protein folding and trafficking.FKBP2 is a cis-trans prolyl isomerase that binds the immunosuppressants FK506 and rapamycin.FKBP2 functions as an ER chaperone and as a component of membrane cytoskeletal scaffolds. |
| 来源 | Human Cells |
| 内毒素 | Less than 0.1 ng/ug(1 EU/ug)as determined by LAL test. |
| 单位 | 支 |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Secretion of Recombinant Human Insulin-Like Growth Factor I (IGF-I)
The development of efficient recombinant protein production processes can be a critical factor in whether or not a pharmaceutical therapeutic protein can enter human clinical trials and ultimately the marketplace. This is especially true
的关系理不出头绪。GSK-3 beta 总蛋白减少,p-GSK-3 beta (ser 9)增加,是不是足以说明有活性的GSK-3 beta 减少更多,这样理解不知道对不对,希望给以指点。 galaxy22 楼主你好,请问你做出结果的tyr216的抗体是哪个公司的。。。我做出来总量是减少的,active B catenin是减少的,那我有必要做ser9 和tyr216的磷酸化形式吗?我想研究wnt和akt。。。 棉花糖的温柔
In this chapter we describe efficient procedures for the construction, expression and screening of comprehensive libraries of human Fab antibody fragments displayed on the surface of filamentous phage. Phagemid vectors are used for placing
技术资料暂无技术资料 索取技术资料





